Fresenius Medical Care Financial Ratios
NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Fresenius Medical Care ratio analysis
Fresenius Medical Care earned a net margin of 22.3% in FY 2013, up from 8.6% a year earlier. Gross margin was 95.3% compared with a median of 33.7% over the prior 6 years. Return on equity reached 12.0%, meaning Fresenius Medical Care generated 0.12 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.86 versus 0.88 the year before, and the current ratio was 1.77. At the end of FY 2013, FMS traded at 9.5 times earnings; across the 7 fiscal years shown, its year-end P/E ranged from 8.7 to 11.1, with a median of 8.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Fresenius Medical Care financial ratios (annual)
| Ratio | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 9.52 | 8.74 | 9.68 | 8.90 | 8.86 | 8.70 | 11.11 |
| Price / sales | 2.11 | 0.74 | 0.81 | 0.72 | 0.69 | 0.66 | — |
| Price / book | 1.14 | 1.14 | 1.29 | 1.16 | 1.17 | 1.17 | — |
| Gross margin | 95.3% | 33.3% | 33.0% | 32.4% | 34.1% | 34.2% | 34.5% |
| Operating margin | 45.4% | 16.1% | 16.5% | 16.2% | 15.6% | 15.8% | 16.3% |
| Net margin | 22.3% | 8.6% | 8.5% | 8.3% | 7.9% | 7.7% | 7.4% |
| Free cash flow margin | 25.9% | 9.9% | 6.8% | 7.1% | 6.8% | 3.1% | 6.4% |
| Return on equity (ROE) | 12.0% | 13.3% | 13.6% | 13.3% | 13.3% | 13.7% | 12.9% |
| Return on assets (ROA) | 4.8% | 5.3% | 5.5% | 5.7% | 5.6% | 5.5% | — |
| Debt / equity | 0.86 | 0.88 | 0.71 | 0.68 | 0.71 | 0.85 | — |
| Current ratio | 1.77 | 1.93 | 1.34 | 1.36 | 1.81 | 1.34 | — |
| Revenue growth | -64.0% | 9.8% | 6.1% | 5.3% | 6.0% | 9.2% | — |
| EPS growth | -5.7% | 10.3% | 8.3% | 8.4% | 9.1% | 13.2% | — |